How RWE can support drug development during COVID-19 and beyond
The COVID-19 pandemic introduced novel challenges for global biopharma organizations, as many...
The COVID-19 pandemic introduced novel challenges for global biopharma organizations, as many...
COVID-19 has heightened the need for an expanded understanding of clinical trial populations and...
Identifying the gaps in today’s real-world data The 2025 IMPACCT Real-World Evidence Summit brought together leaders from biopharma, government, and data science to explore how real-world data is transforming evidence generation across the drug devel...